1.0European Pharmacyhttps://europepharmacy.eu/esinfo@europepharmacy.euhttps://europepharmacy.eu/es/author/infotrusthillpharmacy-com/rich600338<blockquote class="wp-embedded-content" data-secret="gNSHfqQ6jf"><a href="https://europepharmacy.eu/es/shop/retatrutide-10mg/">Retatrutide 10MG</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://europepharmacy.eu/es/shop/retatrutide-10mg/embed/#?secret=gNSHfqQ6jf" width="600" height="338" title="“Retatrutide 10MG” — European Pharmacy" data-secret="gNSHfqQ6jf" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://europepharmacy.eu/wp-includes/js/wp-embed.min.js </script>https://europepharmacy.eu/wp-content/uploads/2026/09/photo_5051033548038540504_x-600x600.jpg600600GLP-1 (glucagon-like peptide-1): Suppresses appetite and slows gastric emptying. GIP (glucose-dependent insulinotropic polypeptide): Enhances insulin secretion and fat metabolism. Glucagon: Promotes energy expenditure and liver fat reduction. It's primarily studied for obesity and type 2 diabetes, showing superior weight loss compared to single- or dual-agonists like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound) in clinical trials. Status: Not FDA-approved (as of October 2024). It's in Phase 3 trials (e.g., TRIUMPH studies), with potential approval expected in 2026–2027. 10 mg Dosage Context Clinical Trial Dosing: Retatrutide is administered weekly via subcutaneous injection. The 10 mg dose is a high-end maintenance dose tested in trials: Phase/Trial Starting Dose Titration Max Dose Weight Loss (at 48–72 weeks) Phase 2 (Obesity) 1 mg Gradual increase every 4 weeks 10 mg** or 12 mg Up to 24.2% body weight loss (vs. 2.1% placebo) Phase 2 (T2D) 0.5 mg Gradual 10 mg ~17% weight loss + A1C reduction Evidence: Phase 2 results (NEJM, 2023): At 10–12 mg, participants lost 17–24% body weight over 48 weeks, with improvements in liver fat, cardiometabolic markers (e.g., blood pressure, lipids), and glycemic control. Superior to tirzepatide's ~20% loss in head-to-head potential (Phase 3 ongoing). Side effects: Mostly GI (nausea, vomiting, diarrhea; 50–70% incidence, dose-dependent). Rare: gallbladder issues, elevated heart rate. Availability and Warnings Not Commercially Available: No official 10 mg vials/pens exist. "Retatrutide 10 mg" products online are typically unregulated research chemicals from compounding pharmacies or overseas labs (e.g., China). Purity is unverified—risk of contamination, underdosing, or fakes. Risks of Unofficial Use: Risk Details Evidence Safety No long-term human data; potential for severe GI issues, pancreatitis, or thyroid tumors (GLP-1 class risk). FDA warnings on compounded semaglutide/tirzepatide analogs. Legality Illegal to buy/sell without prescription in most countries (e.g., US Schedule not yet set, but compounding restricted). DEA/FDA crackdowns on GLP-1 knockoffs. Efficacy Variable potency; lab tests show some "retatrutide" as low as 50% pure. Independent testing (e.g., Janoshik Analytics). Recommendation: Do not self-administer. Consult a doctor for supervised trials or approved alternatives (e.g., tirzepatide). Off-label use lacks safety data—monitor via bloodwork if proceeding under medical guidance.